FORM OF MAGENTA STOCKHOLDER SUPPORT AGREEMENTMagenta Stockholder Support Agreement • May 3rd, 2023 • Magenta Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 3rd, 2023 Company Industry JurisdictionThis Support Agreement (this “Agreement”) is made and entered into as of May 2, 2023, by and among Dianthus Therapeutics, Inc., a Delaware corporation (the “Company”), Magenta Therapeutics, Inc., a Delaware corporation (“Magenta”), and the undersigned stockholder (the “Stockholder”) of Magenta. Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).